NCT01823107View on ClinicalTrials.gov

Feasibility Study of Meso BioMatrix Device for Breast Reconstruction

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2017

Study Completion Date

June 29, 2017

Conditions
Breast Cancer
Interventions
DEVICE

Meso BioMatrix Device

Trial Locations (6)

11530

Long Island Plasic Surgical Group, PC, Garden City

Long Island Plastic Surgical Group, PC, Garden City

19004

Cancer Center of America at Eastern Regional Medical Center / Dr. Glat Plastic & Reconstructive Surgery, Bala-Cynwyd

37232

Vanderbilt University Medical Center, Nashville

48202

Henry Ford Health System, Detroit

84112

University of Utah (Huntsman Cancer Hospital), Salt Lake City

Sponsors
All Listed Sponsors
lead

Kensey Nash Corporation

INDUSTRY

NCT01823107 - Feasibility Study of Meso BioMatrix Device for Breast Reconstruction | Biotech Hunter | Biotech Hunter